Upside:

-SNOA +107% (announces launch of diaper rash product in Walmart and other U.S. chains)

-WULF +27% (signs 200+ MW in two 10-year high-performance computing (HPC) colocation agreements with Fluidstack; Google receive warrants to acquire ~41M shares of TeraWulf common stock)

-DLO +25% (earnings, guidance)

-BMRA +22% (UAE Ministry of Health and Prevention approves Biomerica’s Fortel Ulcer Test for Home Use)

-GRRR +17% (earnings, guidance)

-RRGB +12% (earnings, guidance)

-BLSH +8.9% (post-IPO momentum)

-OBIO +4.9% (announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction)

-EQX +4.1% (earnings, guidance)

-VIPS +3.2% (earnings, guidance)

-WB +3.1% (earnings, guidance)

-HITI +2.4% (to acquire majority stake in Remexian Pharma GmbH)

Downside:

-IBTA -36% (earnings, guidance)

-ATNF -23% (enters $500M at-the-market sales agreement with Clear Street LLC)

-COHR -18% (earnings, guidance)

-SDGR -16% (announces discontinuation of SGR-2921 Program in patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes)

-BMBL -13% (shareholders offering share block at discount to closing price)

-LUNR -11% (prices upsized offering of $300M in convertible senior notes due 2030 [upsized from $250M])

-TPR -11% (earnings, guidance)

-PAGS -6.6% (earnings)

-NTES -6.0% (earnings)

-DE -5.6% (earnings, guidance)

-BIRK -5.0% (earnings, guidance)